CLINICAL_TRIALS
trial_result
· 2016-11-08
Clinical Trial Update: Efficacy of Lu 31-130 in Patients With Schizophrenia [Phase 2]
Summary
Phase 2 clinical trial evaluating Lu 31-130 for schizophrenia has completed, reporting efficacy findings.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED